Joannes-Boyau O - Search Results

1

Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study.

Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honoré PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA. Hoste EA, et al. Intensive Care Med. 2015 Aug;41(8):1411-23. doi: 10.1007/s00134-015-3934-7. Epub 2015 Jul 11. Intensive Care Med. 2015. PMID: 26162677

2

High volume hemofiltration (HVHF) in sepsis: a comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research.

Honore PM, Joannes-Boyau O. Honore PM, et al. Int J Artif Organs. 2004 Dec;27(12):1077-82. doi: 10.1177/039139880402701211. Int J Artif Organs. 2004. PMID: 15645619

3

The big bang of hemofiltration: the beginning of a new era in the third millennium for extra-corporeal blood purification!

Honore' PM, Joannes-Boyau O, Merson L, Boer W, Piette V, Galloy AC, Janvier G. Honore' PM, et al. Int J Artif Organs. 2006 Jul;29(7):649-59. doi: 10.1177/039139880602900702. Int J Artif Organs. 2006. PMID: 16874669 Review.

4

Hemofiltration: The case for removal of sepsis mediators from where they do harm.

Joannes-Boyau O, Honore PM, Boer W. Joannes-Boyau O, et al. Crit Care Med. 2006 Aug;34(8):2244-6. doi: 10.1097/01.CCM.0000227650.77064.5F. Crit Care Med. 2006. PMID: 16883194 No abstract available.

5

The "French Hemodiafe Trial": this study is neither decisive nor definitive in resolving the controversy on renal replacement therapy in ICU.

Honore' PM, Joannes-Boyau O. Honore' PM, et al. Int J Artif Organs. 2006 Dec;29(12):1190-2. doi: 10.1177/039139880602901213. Int J Artif Organs. 2006. PMID: 17219360 Review.

6

CRRT technology and logistics: is there a role for a medical emergency team in CRRT?

Honoré PM, Joannes-Boyau O, Gressens B. Honoré PM, et al. Contrib Nephrol. 2007;156:354-64. doi: 10.1159/000102126. Contrib Nephrol. 2007. PMID: 17464146 Review.

7

Blood and plasma treatments: high-volume hemofiltration--a global view.

Honoré PM, Joannes-Boyau O, Gressens B. Honoré PM, et al. Contrib Nephrol. 2007;156:371-86. doi: 10.1159/000102128. Contrib Nephrol. 2007. PMID: 17464148 Review.

8

Blood and plasma treatments: the rationale of high-volume hemofiltration.

Honoré PM, Joannes-Boyau O, Gressens B. Honoré PM, et al. Contrib Nephrol. 2007;156:387-95. doi: 10.1159/000102129. Contrib Nephrol. 2007. PMID: 17464149 Review.

9

The early biomarker of acute kidney injury: in search of the Holy Grail.

Honore PM, Joannes-Boyau O, Boer W. Honore PM, et al. Intensive Care Med. 2007 Nov;33(11):1866-8. doi: 10.1007/s00134-007-0766-0. Epub 2007 Jul 4. Intensive Care Med. 2007. PMID: 17609928 No abstract available.

10

Acquired deficit of antithrombin and role of supplementation in septic patients during continuous veno-venous hemofiltration.

Lafargue M, Joannes-Boyau O, Honoré PM, Gauche B, Grand H, Fleureau C, Rozé H, Janvier G. Lafargue M, et al. ASAIO J. 2008 Jan-Feb;54(1):124-8. doi: 10.1097/MAT.0b013e31815cc3bf. ASAIO J. 2008. PMID: 18204328

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters